Stelara 90MG/ML SYR 1S
Ended Awarded
- Contract number
- SPE2DX25FKVZQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $47,868
Award facts
- Contract value 100% obligated
- $47,867.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $47,867.73 for Stelara 90mg/ml syringes on September 8, 2025. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency under the SPE2DB program, which carries a total value of $499,999,999 and remains valid through November 2026. This delivery order does not utilize a set-aside designation and employs firm fixed-price pricing, with an ultimate completion date of October 3, 2025. The award is funded by the Medical Supply Chain, a defense-focused federal agency, with performance to occur at the contractor's facility in Park Ridge, Illinois.
Stelara is a branded biologic medication used primarily for the treatment of autoimmune conditions including psoriasis, psoriatic arthritis, and inflammatory bowel disease. Under the SPE2DB vehicle, DMS Pharmaceutical Group serves as a critical supplier in the federal pharmaceutical supply chain, distributing a comprehensive range of prescription medications, biologics, and medical consumables to Department of Defense healthcare facilities nationwide. The company's established portfolio with the Defense Logistics Agency demonstrates consistent capability in delivering specialized pharmaceutical products to military health systems.
Quick answers
Who was awarded contract SPE2DX25FKVZQ?
SPE2DX25FKVZQ was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 8, 2025.
How much is contract SPE2DX25FKVZQ worth?
The government has obligated $47,868 on SPE2DX25FKVZQ.
Is contract SPE2DX25FKVZQ an order under another contract?
Yes. SPE2DX25FKVZQ is a delivery order under SPE2DX15D9628, an indefinite delivery contract.
Was contract SPE2DX25FKVZQ competed?
The extent of competition for SPE2DX25FKVZQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award